Get the Stockscreener App
9.825
4.63%
0.435
Delcath Systems Inc stock is traded at $9.825, with a volume of 358.35K.
It is up +4.63% in the last 24 hours and down -12.90% over the past month.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
See More
Previous Close:
$9.39
Open:
$9.53
24h Volume:
358.35K
Relative Volume:
1.02
Market Cap:
$300.87M
Revenue:
$2.07M
Net Income/Loss:
$-47.68M
P/E Ratio:
-2.9773
EPS:
-3.3
Net Cash Flow:
$-31.31M
1W Performance:
-1.36%
1M Performance:
-12.90%
6M Performance:
+29.79%
1Y Performance:
+301.02%
1-Day Range:
$9.2277
$9.8575
1-Week Range:
$8.87
$10.11
52-Week Range:
$2.4714
$12.88
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| DCTH | 9.825 | 300.87M | 2.07M | -47.68M | -31.31M | -3.30 |
| ABT | 117.63 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 392.54 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.71 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.98 | 112.92B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 70.10 | 40.88B | 6.60B | 4.16B | 490.10M | 2.34 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-26-22 | Resumed | Canaccord Genuity | Buy |
| Dec-10-21 | Initiated | H.C. Wainwright | Buy |
| Mar-09-21 | Initiated | Canaccord Genuity | Buy |
| Jan-05-21 | Initiated | BTIG Research | Buy |
| Jun-01-20 | Initiated | Laidlaw | Buy |
Delcath Systems Inc Stock (DCTH) Latest News
Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth (NASDAQ:DCTH) - Seeking Alpha
(DCTH) Investment Analysis - Stock Traders Daily
Delcath Systems Stock (NASDAQ:DCTH) Among the Best Multibagger Stock to Buy Heading into 2025 - Insider Monkey
Rosalind Advisors, Inc. Increases Stake in Delcath Systems Inc - GuruFocus.com
10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey
Intrahepatic Cholangiocarcinoma Treatment Market size is expected to grow owing to the launch of emerging therapies by 2034, estimates DelveInsight - Barchart
FY2024 EPS Estimate for Delcath Systems Raised by Analyst - MarketBeat
FY2028 EPS Forecast for Delcath Systems Decreased by Analyst - MarketBeat
Uveal melanoma Treatment Market Countermeasures Of Economic - openPR
HC Wainwright Reiterates Buy Rating for Delcath Systems (NASDAQ:DCTH) - MarketBeat
Delcath Systems revenue hits USD 11.2M in Q3 2024, a 44% increase - Medical Buyer
Delcath Systems Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Delcath Systems stock soars to 52-week high of $12 amid robust gains - Investing.com Australia
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2024 Earnings Call Transcript - Insider Monkey
Delcath Systems Reports Strong Q3 Growth and Expansion - TipRanks
Delcath Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 96.84%: Here's is How to Trade - MSN
Delcath Systems Inc (DCTH) Q3 2024 Earnings: Revenue Surpasses E - GuruFocus.com
Delcath Systems, Inc. (DCTH) Reports Q3 Loss - Yahoo Finance
Delcath Systems Revenue Surges 44% to $11.2M as HEPZATO Launch Gains Momentum | DCTH Stock News - StockTitan
Uncovering Potential: Delcath Systems's Earnings Preview - Benzinga
(DCTH) Investment Analysis and Advice - Stock Traders Daily
Delcath Systems (DCTH) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Delcath Systems, Inc. (DCTH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - MSN
Delcath Systems to Participate in Upcoming Investor Conferences - StockTitan
Delcath Systems, Inc.'s (NASDAQ:DCTH) P/S Is Still On The Mark Following 26% Share Price Bounce - Simply Wall St
Comparing Cell MedX (OTCMKTS:CMXC) & Delcath Systems (NASDAQ:DCTH) - Defense World
Delcath Systems (DCTH) to Release Quarterly Earnings on Friday - MarketBeat
Delcath Systems (DCTH) Scheduled to Post Quarterly Earnings on Friday - Defense World
(DCTH) Pivots Trading Plans and Risk Controls - Stock Traders Daily
DCTHDelcath Systems Inc Latest Stock News & Market Updates - StockTitan
Delcath Systems to Host Third Quarter 2024 Earnings Call - StockTitan
Delcath Systems (NASDAQ:DCTH) Upgraded to "Hold" at StockNews.com - MarketBeat
Delcath Systems Inc (DCTH) Trading 3.48% Higher on Oct 22 - GuruFocus.com
Delcath Systems (NASDAQ:DCTH) Rating Lowered to Sell at StockNews.com - Defense World
Delcath shares rise on record sales, analyst reiterates buy rating By Investing.com - Investing.com UK
Analyst Scoreboard: 4 Ratings For Delcath Systems - Benzinga
Delcath shares rise on strong 3Q sales, analyst reiterates buy - Investing.com
Delcath shares rise on strong 3Q sales, analyst reiterates buy By Investing.com - Investing.com South Africa
Delcath Systems' (DCTH) "Buy" Rating Reiterated at Canaccord Genuity Group - MarketBeat
Delcath Systems revenue hits USD 11.2M in Q3 2024 - Medical Buyer
StockNews.com Lowers Delcath Systems (NASDAQ:DCTH) to Sell - MarketBeat
Delcath triggers $25 million financing with Q3 revenue - Investing.com
Delcath Systems, Inc. Announces Preliminary Revenue Results for the Third Quarter of 2024 - Marketscreener.com
Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results - StockTitan
Bullish Delcath Systems Insiders Rewarded As Their Investment Rises To US$1.94m - Simply Wall St
When the Price of (DCTH) Talks, People Listen - Stock Traders Daily
Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Update - MarketBeat
Intrahepatic Cholangiocarcinoma Market Report 2034 | - openPR
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Delcath Systems Inc Stock (DCTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Aharon Gil | Director |
Mar 19 '24 |
Buy |
3.72 |
26,882 |
100,001 |
1,069,710 |
| SALAMON STEVEN A J | Director |
Mar 19 '24 |
Buy |
3.72 |
26,882 |
100,001 |
1,121,025 |
| Vukovic Vojo | Chief Medical Officer |
Dec 12 '23 |
Buy |
3.00 |
40,000 |
120,000 |
100,000 |
| MICHEL GERARD J | Chief Executive Officer |
Dec 08 '23 |
Buy |
2.94 |
34,000 |
99,960 |
262,345 |
1.18%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):